Healthcare Equipment and Supplies
Company Overview of SENSUS Healthcare LLC
SENSUS Healthcare LLC engages in the design, manufacture, and marketing of products and services that incorporate mobile X-ray technology for the non-invasive treatment of non-melanoma skin cancers. It offers mobile and compact SRT-100, a non-invasive procedure for use by oncologists and dermatologists for the treatment of non-melanoma skin cancer in patients. The company also provides pre-installation coordination, training, IT solutions, and financing services. It serves dermatology and oncology practices, cancer centers, hospitals, multi-locale healthcare providers, and veterinary clinics worldwide. SENSUS Healthcare LLC was incorporated in 2010 and is based in Boca Raton, Florida.
851 Broken Sound Parkway NW
Boca Raton, FL 33487
Founded in 2010
Key Executives for SENSUS Healthcare LLC
Chairman, Chief Executive Officer and President
Chief Operating Officer and Chief Technology Officer
Executive Vice President of Oncology and International Sales
Senior Vice President of Strategic Initiatives and Dermatology
Compensation as of Fiscal Year 2014.
SENSUS Healthcare LLC Key Developments
Sensus Healthcare Announces Mark Nestor as Clinical Director
Aug 28 13
Sensus Healthcare announced Dr. Mark Nestor as Clinical Director. Dr. Nestor joins a panel of Medical Advisory Board Members. He will lead the Company's efforts in the areas of Training, Education, and Clinical research as the Company continues to expand its SRT technology for non-invasive skin cancer treatment for NMSC as well as treatment for Keloid scars. Dr. Nestor is a practicing dermatologist in Aventura, Florida where he is Director of the Center for Clinical and Cosmetic Research.
SENSUS Healthcare LLC Presents at IN3 Med Device 360° - Boston, Jun-25-2013 04:30 PM
Jun 6 13
SENSUS Healthcare LLC Presents at IN3 Med Device 360° - Boston, Jun-25-2013 04:30 PM. Venue: The Hyatt Boston, One Avenue De Lafayette, Boston, MA 02111, United States.
Sensus Healthcare Receives FDA Clearance to Treat Keloids with the SRT-100(TM)
May 24 13
Sensus Healthcare announced that it has received clearance from the U.S. Food and Drug Administration to treat Keloids with the SRT-100(TM). The SRT-100(TM) is the leading alternative to surgery in treating Non Melanoma Skin Cancer and now is approved to treat Keloids caused by surgery or injury. The SRT-100(TM) superficial radiotherapy system to be an excellent choice for their patients who are not good surgical candidates. Sensus Healthcare has reintroduced superficial radiotherapy (SRT) to the global clinical community as a viable, safe, and cost-effective modality to treat non-melanoma skin cancers and keloids in hospitals and private practice settings. SRT-100(TM) is an ideal treatment modality for non-melanoma skin cancers and keloids.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries